News
Every year, more than one million scientific articles are published in the life sciences. Two-thirds of them include ...
Innovation starts with understanding your customer. This simple framework helps uncover real problems and engineer meaningful ...
Here we use cryogenic electron microscopy to determine the structure of TbAQP2 from Trypanosoma brucei, bound to either the substrate glycerol or to the sleeping sickness drugs, pentamidine or ...
All companies want to provide their customers with richer and more engaging experiences. The challenge is how to scale the experiences in a way that does not depersonalize or commodify them. Enter ...
Gilead and Novo Nordisk have announced that a study testing various drug combinations for the fatty liver disease known as NASH has checked out in a mid-stage proof-of-concept study.
The updated ICH E6 (R3) Good Clinical Practice guidelines are here - discover what's changed and how clinical trials will need to adapt. This in-depth post unravels the key impacts of E6 (R3).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results